Susquehanna International Group
PEARW

Susquehanna International Group’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Susquehanna International Group’s Portfolio PEARW Stock Details PEARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-48,392
Closed -$919 – 13734
2023
Q1 		$919 Buy
+48,392
New +$4.66K ﹤0.01% 12422
2022
Q3 		– Sell
-11,725
Closed -$1K – 14535
2022
Q2 		$1K Buy
+11,725
New +$5.79K ﹤0.01% 12740
2021
Q4 		– Sell
-12,305
Closed -$12K – 14234
2021
Q3 		$12K Buy
+12,305
New +$12.8K ﹤0.01% 12597

Other funds holding PEARW

AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Susquehanna International Group's PEARW Position: Q2 2023 in Review

Susquehanna International Group sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 48,392 shares — an estimated $919 sold.

Susquehanna International Group first reported a position in PEARW in Q3 2021 and held it in 3 quarters. The position peaked at $12K in Q3 2021. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

  • Susquehanna International Group reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 48,392 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $919.
  • Susquehanna International Group first reported a position in Pear Therapeutics, Inc. Warrant in Q3 2021 and held it in 3 quarters.
  • Susquehanna International Group's Pear Therapeutics, Inc. Warrant position peaked at $12K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.